EnWave Announces 2021 Second Quarter Consolidated Interim Financial Results
VANCOUVER, MAY 27, 2021 6:00AM
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reports the Company’s consolidated interim financial results for the second quarter ended March 31, 2021.

EnWave’s annual and interim consolidated financial statements and MD&As are available on SEDAR at www.sedar.com and on the Company’s website www.enwave.net.
Finanzielle Höhepunkte für das 2. Quartal (in Tausend Euro):
- Reported consolidated revenue for Q2 2021 of $4,686 compared to $7,492 for Q2 2020, a decrease of $2,806 or 37%.
- Revenue from EnWave in Q2 2021 was $2,348 compared to $2,169 in Q2 2020, an increase of $179 or 8%. The increase in revenue was due to higher Radiant Energy Vacuum (“REV™”) machine rentals for technology evaluation purposes and higher customized REV™” machinery sales in the food and cannabis verticals.
- Revenue from NutraDried in Q2 2021 was $2,338 compared to $5,323 in Q2 2020, a decrease of $2,985 or 56%. NutraDried revenues were downwardly impacted by fewer rotations with Costco, partially offset by some growth in the online channels.
- Gross margin for Q2 2021 was 10% compared to 25% for Q2 2020. The margin compression in Q2 2021 was due to lower manufacturing cost absorption at NutraDried with manufacturing overhead being allocated over reduced production volume. NutraDried also recorded an inventory write-off provision of $213 during the period. EnWave’s segment gross margin improved to 40% during the quarter as the REV™ business continued to benefit from a more variable cost structure while reducing fixed manufacturing overhead expenses.
- Consolidated net loss after taxes was $2,286 for Q2 2021 compared to a net loss $1,850 for Q2 2020.
- EnWave reported positive segment net income of $42 for Q2 2021 compared to a segment loss of $1,134 for Q2 2020, an improvement of $1,176. The improvement in EnWave’s segment results is attributed to the growth in REV™ machinery orders paired with measures implemented to reduce costs in all areas of the business.
- NutraDried reported a segment loss of $2,328 for Q2 2021 compared to a segment loss of $716 for Q2 2020. This increase is primarily due to the one-time severance charge of $691 for the restructuring of NutraDried, as well as lower gross margins due to not having Costco rotations during the period. In February 2021, the Company announced a restructuring of NutraDried and has taken significant steps to reduce NutraDried’s expenses and increase manufacturing output.
- Adjusted EBITDA(*) was a loss of $1,968 for Q2 2021 compared to a loss of $1,462 for Q2 2020, an increase of $506.
- SG&A expenses (inclusive of R&D expenses) for Q2 2021 were a combined $2,981 compared to $3,835 for Q2 2020 and $3,216 for Q1 2021. The Company reduced SG&A expenses by reducing non-essential spending and discretionary expenses while remaining focused on the core competencies of the business and planning for future growth.
- Continue to maintain a strong balance sheet with a working capital surplus of $19,275 and a cash position of $15,403. We are in a strong position to pursue further growth in the expansion of the global deployment of REV™ technology, which includes the build-out of the REVworx™ toll manufacturing facility which is expected to be operational by the end of the fiscal year.
Significant Corporate Accomplishments in Q2 2021:
Significant accomplishments made during Q2 2021 and to the date of this report include:
- Signed a royalty-bearing commercial license agreement with a leading Illinois-based cannabis company to produce cannabis products and received a purchase order for both a large-scale 120kW machine and a 10kW pilot-scale REV™
- Signed a royalty-bearing commercial license agreement with AvoLov, LLC (d.b.a. “BranchOut”) and sold a 60kW large-scale REV™ machine to initiate production of a line of “better-for-you” avocado and fruit products.
- Completed the sale of a 10kW REV™ machine to NuWave Foods, Inc., who was previously on a Technology Evaluation and License Option Agreement, for the commercial launch of new and innovative shelf-stable bakery products.
- Received a purchase order to deliver a 10kW REV™ machine to Dairy Concepts IRL (“DCI”) for the development of a portfolio of natural, sweet and savoury, shelf-stable, hand-held dairy snacks.
- The US Army submitted a purchase order for the delivery of a second 10kW REV™ machine for the accelerated development of unique, lighter and nutrient-dense food ration products for soldiers. The machine will be placed at the Bridgford Foods Corporation (NASDAQ: BRID) manufacturing facility for the joint development of commercially viable military ration components.
- Natural Nutrition, the Company’s royalty partner in Chile, purchased two additional 10kW REV™ machines for installation in the agriculturally rich Northern Patagonia region of Chile to increase its royalty-bearing processing capacity for premium dried fruit and vegetable products.
- Received a purchase order for a 10kW REV™ machine from Responsible Foods, a royalty partner of the Company producing premium dried snacks using healthy Icelandic ingredients. The purchase of the 10kW machine doubles Responsible Foods’ royalty-bearing manufacturing capacity in Iceland.
- Completed the installation and start-up of two 100kW REV™ machines for Pitalia and Consulting Fresh Business S.L. in Costa Rica and Peru, respectively. Both companies began commercial production during fiscal Q2 and pays EnWave a royalty based on a percentage of revenue generated from REV™ product sales.
- Signed three new Technology Evaluation and License Option Agreements with companies conducting intensive product development and evaluation on the use of REV™ technology to bring innovative new products to market.
- NutraDried launched a new Protein Blitz Mix product in three flavours (Gouda Pecan Zesty Ranch, Almond Crazy Cheesy, Sweet Heat) which is available in various package sizes ranging from 1oz to 15oz that have been customized to suit specific channels of distribution.
- Completed a material restructuring at NutraDried with the objective to restore the operating subsidiary to sustainable profitability. The Company parted ways with the former CEO of NutraDried and took significant steps to remove excess staffing, marketing and SG&A expenses from the business, the benefit of which will be realized in the second half of 2021. Starting in Q3, NutraDried has successfully started to build a co-manufacturing business for the sale of shelf-stable cheese as ingredients in other snack products and mixes, and current management plan to leverage the installed REV™ capacity to bring additional products to market.
- Announced that Merck published a research paper citing the Company’s freezeREV® process as a viable manufacturing alternative to vial-based lyophilization for vaccines and biologics, while emphasizing the need for accelerated vaccine development and on-demand, flexible manufacturing options especially in this global pandemic environment.
- Repurchased and cancelled 40,000 common shares under the normal course issuer bid for a total cost of $53 at a volume weighted average price of $1.32 per common share.
Details zur Telefonkonferenz:
Date: May 27, 2021
Time: 7:00am PST / 10:00am EST
Participant Access: 1-877-407-2988 (toll free number)
Webcast Link:
https://78449.themediaframe.com/dataconf/productusers/enw/mediaframe/45178/indexl.html
DOWNLOAD THIS RELEASE
(*) Nicht-IFRS-Finanzkennzahlen:
Adjusted EBITDA is not a measure of financial performance under IFRS. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring and severance charges and government assistance. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the discussion included in the Company’s interim MD&A for the six months ended March 31, 2021.
Über EnWave
Die EnWave Corporation, ein fortschrittliches Technologieunternehmen mit Sitz in Vancouver, hat ein Strahlungsenergie-Vakuum ("REV™") entwickelt - eine innovative, geschützte Methode zur präzisen Dehydrierung organischer Materialien. EnWave hat darüber hinaus patentierte Methoden zur gleichmäßigen Trocknung und Dekontaminierung von Cannabis durch den Einsatz der REV™-Technologie entwickelt, wodurch die Zeit von der Ernte bis zum marktfähigen Cannabisprodukt verkürzt wird.
Die kommerzielle Lebensfähigkeit der REV™-Technologie wurde nachgewiesen und wächst schnell in verschiedenen vertikalen Märkten im Lebensmittel- und Pharmasektor, einschließlich legalem Cannabis. Die Strategie von EnWave besteht darin, lizenzpflichtige kommerzielle Lizenzen mit innovativen, bahnbrechenden Unternehmen in verschiedenen Branchen für die Nutzung der REV™-Technologie zu unterzeichnen. Das Unternehmen hat bis heute über dreißig lizenzpflichtige Lizenzen unterzeichnet. Zusätzlich zu diesen Lizenzen gründete EnWave eine Gesellschaft mit beschränkter Haftung, NutraDried Food Company, LLC, zur Herstellung, Vermarktung und zum Verkauf von natürlichen Milchsnackprodukten in den Vereinigten Staaten, einschließlich der Marke Moon Cheese®.
EnWave hat REV™ als neuen Standard für die Trocknung von Lebensmitteln und biologischem Material eingeführt: schneller und kostengünstiger als Gefriertrocknung, mit besserer Endproduktqualität als Luft- oder Sprühtrocknung. EnWave verfügt derzeit über drei kommerzielle REV™-Plattformen:
1. nutraREV®, das in der Lebensmittelindustrie zur schnellen und kostengünstigen Trocknung von Lebensmitteln eingesetzt wird, wobei ein hohes Maß an Nährwert, Geschmack, Textur und Farbe erhalten bleibt; und
2. quantaREV®, das für die kontinuierliche, hochvolumige Trocknung bei niedrigen Temperaturen eingesetzt wird.
Weitere Informationen über EnWave finden Sie unter www.enwave.net.
EnWave Corporation
Herr Brent Charleton, CFA
Präsident & CEO
Für weitere Informationen:
Brent Charleton, CFA
Präsident und CEO unter +1 (778) 378-9616
E-Mail: bcharleton@enwave.net
Dan Henriques, CA, CPA,
Finanzvorstand unter +1 (604) 835-5212
E-Mail: dhenriques@enwave.net
Für Medienanfragen:
E-Mail: media@enwave.net
Safe Harbour für zukunftsgerichtete Informationen: Diese Pressemitteilung kann zukunftsgerichtete Informationen enthalten, die auf den Erwartungen, Schätzungen und Prognosen der Geschäftsleitung basieren. Alle Aussagen, die sich auf Erwartungen oder Prognosen über die Zukunft beziehen, einschließlich Aussagen über die Wachstumsstrategie des Unternehmens, die Produktentwicklung, die Marktposition, die erwarteten Ausgaben und die erwarteten Synergien nach dem Abschluss der Transaktion, sind zukunftsgerichtete Aussagen. Für die Richtigkeit aller Angaben Dritter, auf die in dieser Mitteilung Bezug genommen wird, wird keine Garantie übernommen. Alle Verweise Dritter auf Marktinformationen in dieser Mitteilung sind ohne Gewähr, da das Unternehmen die ursprüngliche Primärforschung nicht durchgeführt hat. Diese Aussagen sind keine Garantie für zukünftige Leistungen und beinhalten eine Reihe von Risiken, Ungewissheiten und Annahmen. Obwohl das Unternehmen versucht hat, wichtige Faktoren zu identifizieren, die dazu führen könnten, dass die tatsächlichen Ergebnisse wesentlich abweichen, kann es andere Faktoren geben, die dazu führen, dass die Ergebnisse nicht wie erwartet, geschätzt oder beabsichtigt ausfallen. Es kann nicht garantiert werden, dass sich solche Aussagen als zutreffend erweisen, da die tatsächlichen Ergebnisse und zukünftigen Ereignisse erheblich von den in solchen Aussagen erwarteten abweichen können. Dementsprechend sollten sich die Leser nicht zu sehr auf zukunftsgerichtete Aussagen verlassen.
Weder die TSX Venture Exchange noch ihr Regulierungsdienstleister (gemäß der Definition dieses Begriffs in den Richtlinien der TSX Venture Exchange) übernehmen die Verantwortung für die Angemessenheit oder Richtigkeit dieser Pressemitteilung.